<info type="ChemicalEntity">Phenylephrine</info> but not <info type="ChemicalEntity">ephedrine</info> reduces <info type="DiseaseOrPhenotypicFeature">frontal lobe oxygenation</info> following <info type="DiseaseOrPhenotypicFeature">anesthesia-induced hypotension</info>.

BACKGROUND: <info type="ChemicalEntity">Vasopressor agents</info> are used to correct <info type="DiseaseOrPhenotypicFeature">anesthesia-induced hypotension</info>. We describe the effect of <info type="ChemicalEntity">phenylephrine</info> and <info type="ChemicalEntity">ephedrine</info> on <info type="DiseaseOrPhenotypicFeature">frontal lobe oxygenation</info> (<info type="GeneOrGeneProduct">S(c)O(2)</info>) following <info type="DiseaseOrPhenotypicFeature">anesthesia-induced hypotension</info>. METHODS: Following induction of <info type="DiseaseOrPhenotypicFeature">anesthesia</info> by <info type="ChemicalEntity">fentanyl</info> (<info type="ChemicalEntity">0.15 mg kg(-1)</info>) and <info type="ChemicalEntity">propofol</info> (<info type="ChemicalEntity">2.0 mg kg(-1)</info>), <info type="OrganismTaxon">13 patients</info> received <info type="ChemicalEntity">phenylephrine</info> (<info type="ChemicalEntity">0.1 mg iv</info>) and <info type="OrganismTaxon">12 patients</info> received <info type="ChemicalEntity">ephedrine</info> (<info type="ChemicalEntity">10 mg iv</info>) to restore <info type="GeneOrGeneProduct">mean arterial pressure</info> (<info type="GeneOrGeneProduct">MAP</info>). <info type="GeneOrGeneProduct">Heart rate</info> (<info type="GeneOrGeneProduct">HR</info>), <info type="GeneOrGeneProduct">MAP</info>, <info type="GeneOrGeneProduct">stroke volume</info> (<info type="GeneOrGeneProduct">SV</info>), <info type="GeneOrGeneProduct">cardiac output</info> (<info type="GeneOrGeneProduct">CO</info>), and <info type="GeneOrGeneProduct">frontal lobe oxygenation</info> (<info type="GeneOrGeneProduct">S(c)O(2)</info>) were registered. RESULTS: Induction of <info type="DiseaseOrPhenotypicFeature">anesthesia</info> was followed by a decrease in <info type="GeneOrGeneProduct">MAP</info>, <info type="GeneOrGeneProduct">HR</info>, <info type="GeneOrGeneProduct">SV</info>, and <info type="GeneOrGeneProduct">CO</info> concomitant with an elevation in <info type="GeneOrGeneProduct">S(c)O(2)</info>. After administration of <info type="ChemicalEntity">phenylephrine</info>, <info type="GeneOrGeneProduct">MAP</info> increased (<info type="GeneOrGeneProduct">51 +/- 12 to 81 +/- 13 mmHg</info>; <info type="GeneOrGeneProduct">P</info> < <info type="GeneOrGeneProduct">0.001</info>; <info type="GeneOrGeneProduct">mean +/- SD</info>). However, a <info type="GeneOrGeneProduct">14%</info> (<info type="GeneOrGeneProduct">from 70 +/- 8% to 60 +/- 7%</info>) reduction in <info type="GeneOrGeneProduct">S(c)O(2)</info> (<info type="GeneOrGeneProduct">P</info> < <info type="GeneOrGeneProduct">0.05</info>) followed with no change in <info type="GeneOrGeneProduct">CO</info> (<info type="GeneOrGeneProduct">3.7 +/- 1.1 to 3.4 +/- 0.9 l min(-1)</info>). The administration of <info type="ChemicalEntity">ephedrine</info> led to a similar increase in <info type="GeneOrGeneProduct">MAP</info> (<info type="GeneOrGeneProduct">53 +/- 9 to 79 +/- 8 mmHg</info>; <info type="GeneOrGeneProduct">P</info> < <info type="GeneOrGeneProduct">0.001</info>), restored <info type="GeneOrGeneProduct">CO</info> (<info type="GeneOrGeneProduct">3.2 +/- 1.2 to 5.0 +/- 1.3 l min(-1)</info>), and preserved <info type="GeneOrGeneProduct">S(c)O(2)</info>. CONCLUSIONS: The utilization of <info type="ChemicalEntity">phenylephrine</info> to correct <info type="DiseaseOrPhenotypicFeature">hypotension</info> induced by <info type="DiseaseOrPhenotypicFeature">anesthesia</info> has a negative impact on <info type="GeneOrGeneProduct">S(c)O(2)</info> while <info type="ChemicalEntity">ephedrine</info> maintains <info type="DiseaseOrPhenotypicFeature">frontal lobe oxygenation</info> potentially related to an increase in <info type="GeneOrGeneProduct">CO</info>.